Generally, “subsidiary” refers to a private Fortress subsidiary, “partner company” refers to a public Fortress subsidiary, and “partner” refers to entities with whom one of the foregoing parties has a significant business relationship, such as an exclusive license or an ongoing product-related payment obligation.
Most subsidiary/partner companies provide Fortress with an annual 2.5% equity dividend and a 4.5% royalty on net sales when such sales exist. This incentivizes Fortress to continue to build value over time. Subsidiary/partner companies and Fortress can share resources, personnel, and expertise. Fortress provides all business development efforts including active identification of synergistic portfolio assets and provides ongoing operational, strategic, administrative support.
Get in Touch
For questions regarding our company, drug candidates, marketed products, business development opportunities, or for general inquiries, please reach out to us.Ask a Question